Skip to main content
Premium Trial:

Request an Annual Quote

NIH to Advance Bioinformatics Research with $5M in Annual Funding

NEW YORK (GenomeWeb News) – The National Library of Medicine plans to grant up to $5 million dollars per year to fund a number of research programs that can help advance biomedical informatics, according to the National Institutes of Health.
 
The NIH research project grant, which is a reissue of a 2005 funding program, will support between 12 and 15 programs for up to three years, NIH said.
 
Informatics issues the NLM is interested in pursuing include integrating information from various sources; new approaches for linking phenomic and genomic information; information retrieval techniques for databases and data mining techniques; modeling and simulation techniques; techniques for visualization and presentation of information; and information analysis and evaluation.
 
Application areas could include health care, public health, basic biological and behavioral research, complex modeling, and clinical translational research.
 
More information about this funding program can be found here.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.